Adamis Pharma Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Adamis Pharma are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Adamis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Adamis Pharma is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 23.3 M |
Adamis |
Adamis Pharma Relative Risk vs. Return Landscape
If you would invest (100.00) in Adamis Pharma on December 20, 2024 and sell it today you would earn a total of 100.00 from holding Adamis Pharma or generate -100.0% return on investment over 90 days. Adamis Pharma is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Adamis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Adamis Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Adamis Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Adamis Pharma, and traders can use it to determine the average amount a Adamis Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ADMP |
Based on monthly moving average Adamis Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adamis Pharma by adding Adamis Pharma to a well-diversified portfolio.
Adamis Pharma Fundamentals Growth
Adamis Stock prices reflect investors' perceptions of the future prospects and financial health of Adamis Pharma, and Adamis Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Adamis Stock performance.
| Return On Equity | -7.85 | |||
| Return On Asset | -1.04 | |||
| Operating Margin | (3.74) % | |||
| Current Valuation | 7.28 M | |||
| Shares Outstanding | 9.36 M | |||
| Price To Earning | (6.21) X | |||
| Price To Book | 8.62 X | |||
| Price To Sales | 17.64 X | |||
| Revenue | 4.76 M | |||
| EBITDA | (24.27 M) | |||
| Cash And Equivalents | 8.88 M | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 342.56 K | |||
| Debt To Equity | 0.16 % | |||
| Book Value Per Share | (4.24) X | |||
| Cash Flow From Operations | (25.9 M) | |||
| Earnings Per Share | (10.14) X | |||
| Total Asset | 10.93 M | |||
| Retained Earnings | (304.56 M) | |||
| Current Asset | 4.15 M | |||
| Current Liabilities | 2.75 M | |||
Things to note about Adamis Pharma performance evaluation
Checking the ongoing alerts about Adamis Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Adamis Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Adamis Pharma is not yet fully synchronised with the market data | |
| Adamis Pharma has some characteristics of a very speculative penny stock | |
| Adamis Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 4.76 M. Net Loss for the year was (26.48 M) with loss before overhead, payroll, taxes, and interest of (1.43 M). | |
| Adamis Pharma currently holds about 8.88 M in cash with (25.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. |
- Analyzing Adamis Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Adamis Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Adamis Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Adamis Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Adamis Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Adamis Pharma's stock. These opinions can provide insight into Adamis Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Adamis Stock
If you are still planning to invest in Adamis Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adamis Pharma's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets |